Sean Bohen
President and CEO at Olema Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Olema Pharmaceuticals Inc., 3 years.
Olema Pharmaceuticals Inc.
Director · PRESIDENT AND CEO
Chief executive roles
Olema Pharmaceuticals Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 26, 2025 | Olema Pharmaceuticals Inc. | Gift | −8,500 | — | — |
| Dec 11, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −55,907 | $8.66 | $484,155 |
| Dec 11, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −1,267 | $9.39 | $11,897 |
| Dec 10, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −52,328 | $9.37 | $490,313 |
| Dec 9, 2024 | Olema Pharmaceuticals Inc. | Grant or award | +204,750 | — | — |
| Nov 22, 2023 | Olema Pharmaceuticals Inc. | Open-market sale | −27,932 | $13.90 | $388,255 |
| Nov 21, 2023 | Olema Pharmaceuticals Inc. | Open-market sale | −26,691 | $14.84 | $396,094 |
| Nov 21, 2023 | Olema Pharmaceuticals Inc. | Open-market sale | −2,602 | $15.29 | $39,785 |
| Nov 20, 2023 | Olema Pharmaceuticals Inc. | Grant or award | +110,250 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.